Iran : ça va mieux
👉 Dossier Municipales à Marseille : guerre des gangs pour un point de deal
👉 Grâce à l'IA, une Shoah instagrammable
👉 Saumon d'élevage : le poison est dans le poisson
En vente mercredi !
Today is International Myotonic Dystrophy Awareness day. Myotonic dystrophy is the most common form of adult muscular dystrophy. There is currently no cure and there are no approved treatments. Our members are working to better understand the condition and how to manage it.
@AirTalk Hi Larry, the problem is not the cost it is the lack of reliability and access. There is not enough coverage geographically and not sticking to schedule. Look at Europe and we should be really ashamed. As long as car and oil company lobbyists are much powerful, we don’t get much.
PR: Avidity Announces Positive AOC 1001 Phase 1/2 MARINA™ Data Demonstrating First-Ever Successful Targeted Delivery of RNA to Muscle - Revolutionary Advancement for the Field of RNA Therapeutics https://t.co/DbTy43HqVo via @YahooFinance
The numbers are in for #WMS2022. What an incredible congress, with some wonderful feedback from those attending both in-person and online. If you missed out this year, be sure to save the date for Charleston in 2023: https://t.co/BwwKl8IuOu
Following a successful election process, we were delighted to announce the new Executive Board at the WMS 2022 Congress in Halifax, Canada. Meet the board here: https://t.co/23URlvIZNX
We are pleased to share just a few highlights from WMS2022. From meeting with old friends, exploring truly inspiring research & making new connections in the neuromuscular research community, it was a truly memorable event. What was your best moment? https://t.co/AHmJ11y1YX
Our test can thus be used to rule out LGMDD4 in patients with only one CAPN3 variant identified (if this variant has the “recessive” pattern) – high clinical impact by helping to find the right diagnosis faster! #WMS2022@WorldMuscleSoc